Ditchcarbon
  • Contact
  1. Organizations
  2. Roche Holding AG
Public Profile
Pharmaceutical Preparation Manufacturing
CH
updated 2 months ago

Roche Holding AG Sustainability Profile

Company website

Roche Holding AG, commonly referred to as Roche, is a leading global healthcare company headquartered in Basel, Switzerland (CH). Founded in 1896, Roche has established itself as a pioneer in the pharmaceutical and diagnostics industries, focusing on innovative solutions for oncology, immunology, infectious diseases, and personalised medicine. With a strong presence in Europe, North America, and Asia, Roche is renowned for its commitment to research and development, producing unique products such as targeted therapies and advanced diagnostic tools. The company’s robust portfolio includes well-known medications like Herceptin and Avastin, which have transformed cancer treatment. Roche's dedication to innovation has earned it a prominent market position, consistently ranking among the top pharmaceutical companies globally. Its achievements in personalised healthcare and diagnostics underscore its role as a leader in advancing medical science and improving patient outcomes.

DitchCarbon Score

How does Roche Holding AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

89

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

Roche Holding AG's score of 89 is higher than 92% of the industry. This can give you a sense of how well the company is doing compared to its peers.

92%

Let us know if this data was useful to you

Roche Holding AG's reported carbon emissions

In 2024, Roche Holding AG reported total carbon emissions of approximately 5,500,000 kg CO2e across all scopes. This includes about 246,000 kg CO2e from Scope 1, approximately 69,000 kg CO2e from Scope 2, and a significant 5,478,525,000 kg CO2e from Scope 3 emissions. The Scope 3 emissions are primarily driven by purchased goods and services, which account for about 3,886,248,000 kg CO2e. Roche has set ambitious climate commitments, aiming for a 42% reduction in Scope 1 and 2 emissions and a 25% reduction in Scope 3 emissions by 2030, compared to 2022 levels. Additionally, the company has committed to achieving net-zero emissions across its entire value chain by 2045. Near-term targets include a 70% reduction in absolute Scope 1 and 2 emissions by 2029 from a 2022 baseline, alongside a 22.5% reduction in specific Scope 3 emissions categories within the same timeframe. Roche's emissions data is sourced directly from the company, with no cascading from a parent organization. The company is actively working towards its sustainability goals, aligning with industry standards and science-based targets to mitigate its environmental impact.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20132014201520162017201820192020202220232024
Scope 1
403,136,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 2
-
-
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
00,000,000
00,000,000
Scope 3
188,924,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
00,000,000
0,000,000,000
0,000,000,000
0,000,000,000

How Carbon Intensive is Roche Holding AG's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Roche Holding AG's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Roche Holding AG's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Roche Holding AG is in CH, which has a very low grid carbon intensity relative to other regions.

Roche Holding AG's Scope 3 Categories Breakdown

Roche Holding AG's Scope 3 emissions, which decreased by 8% last year and increased significantly since 2013, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 71% of Scope 3 emissions.

Top Scope 3 Categories

2024
Purchased Goods and Services
71%
Capital Goods
10%
Upstream Transportation & Distribution
5%
End-of-Life Treatment of Sold Products
4%
Use of Sold Products
4%
Business Travel
3%
Fuel and Energy Related Activities
1%
Employee Commuting
1%
Investments
1%
Waste Generated in Operations
<1%

Roche Holding AG's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Roche Holding AG has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Roche Holding AG's Emissions with Industry Peers

Glaxosmithkline

GB
•
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Joint Stock Company Pharmstandard

RU
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Bayer

DE
•
Chemicals nec
Updated 12 days ago

Nippon Shinyaku Co

JP
•
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Merck And Co

US
•
Pharmaceutical Preparation Manufacturing
Updated 6 days ago

Novartis

CH
•
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Frequently Asked Questions

Common questions about Roche Holding AG's sustainability data and climate commitments

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251114.2
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
AWS Marketplace logo
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy